tiprankstipranks
ATRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsATRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Atara reduction in workforce to impact 50% of current employees
Premium
The Fly
Atara reduction in workforce to impact 50% of current employees
2M ago
Atara Biotherapeutics price target lowered to $5 from $10 at Stifel
Premium
The Fly
Atara Biotherapeutics price target lowered to $5 from $10 at Stifel
2M ago
Atara Biotherapeutics remains eligible for $60M milestone payment
PremiumThe FlyAtara Biotherapeutics remains eligible for $60M milestone payment
3M ago
Atara announces Ebvallo CRL did not find clinical efficacy deficiencies
Premium
The Fly
Atara announces Ebvallo CRL did not find clinical efficacy deficiencies
3M ago
Atara Biotherapeutics expands review of strategic alternatives for CAR-T assets
Premium
The Fly
Atara Biotherapeutics expands review of strategic alternatives for CAR-T assets
3M ago
Atara Biotherapeutics price target raised to $21 from $13 at Canaccord
PremiumThe FlyAtara Biotherapeutics price target raised to $21 from $13 at Canaccord
5M ago
Atara Biotherapeutics Advances with Strategic Partnerships
Premium
Company Announcements
Atara Biotherapeutics Advances with Strategic Partnerships
5M ago
Atara Biotherapeutics reports Q3 EPS ($2.93), consensus ($1.93)
Premium
The Fly
Atara Biotherapeutics reports Q3 EPS ($2.93), consensus ($1.93)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100